Advertisement
European Society for Vascular Surgery
Advanced searchSave search
Coup D’Oeil| Volume 50, ISSUE 1, P77, July 2015

A Periscope-Based Parallel Endografting Approach Can Successfully Exclude an Aneurysm of the Left Subclavian Artery Origin

Open ArchivePublished:May 21, 2015DOI:https://doi.org/10.1016/j.ejvs.2015.04.022
A Periscope-Based Parallel Endografting Approach Can Successfully Exclude an Aneurysm of the Left Subclavian Artery Origin
Previous ArticlePotential Interactions Between Genetic Polymorphisms of the Transforming Growth Factor-β Pathway and Environmental Factors in Abdominal Aortic Aneurysms
Next ArticleTrends in Major Lower Limb Amputation Related to Peripheral Arterial Disease in Hungary: A Nationwide Study (2004–2012)
      Figure thumbnail fx1
      An 86-year-old female presented with a 3-cm saccular aneurysm at the left subclavian artery (LSA) origin, effectively providing only one landing zone for endografting. This was successfully excluded under regional anaesthesia using a thoracic stent-graft (38 × 77 mm TX2, Cook Aortic Intervention) with a heparin-bonded endoprosthesis (10 × 150 mm Viabahn, Gore Medical) deployed in periscope configuration. Both remain patent 8 months later, with LSA aneurysm exclusion and no endoleakage. Such endovascular techniques avoid the morbidity of open bypass surgery and waiting times for a customised/fenestrated device, and provide an alternative for aneurysms of the aortic arch outflow where only single landing zones are available.

      Article info

      Publication history

      Published online: May 21, 2015
      Accepted: April 19, 2015
      Received: April 7, 2015

      Identification

      DOI: https://doi.org/10.1016/j.ejvs.2015.04.022

      Copyright

      © 2015 European Society for Vascular Surgery. Published by Elsevier Inc.

      User license

      Elsevier user license |
      How you can reuse Information Icon
      Elsevier user license

      Permitted

      For non-commercial purposes:

      • Read, print & download
      • Text & data mine
      • Translate the article

      Not Permitted

      • Reuse portions or extracts from the article in other works
      • Redistribute or republish the final article
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect

      Comments

      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX